Nearly half of retirees in 2018 retired before age 62, and one-fourth retired between the ages of 62 and 64.
Cost may be a major issue limiting adoption of gene therapy, but it's not the only one.
How can employers be confident they are offering the right coverage to employees and their families?
Sponsored by Gallagher
- Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
- Exclusive discounts on BenefitsPRO.com and ALM events.
Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.